Accurate internal dosimetry for your radiopharmaceutical at any stage of development!

In our partnership with Internal Dosimetry Consultants, we can help you determine accurate internal dosimetry for your radiopharmaceutical at any stage of development, preclinical research to clinical practice. For example, we can calculate the total absorbed dose in your preclinical model, determine a safe starting dose for your Phase 1 clinical trial, determine the dose equivelant of a targeted radionuclide therapy agent to an external beam therapy prescription, or determine what absorbed dose your patient received.

Internal Dosimetry Consultants is insured and certified to handle protected health information (PHI).

Contact Us for more information.